Thermo Fisher Scientific Inc.
TMO
$509.98
-$2.67-0.52%
| 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.83B | 1.63B | 1.55B | 1.33B | 1.63B |
| Total Depreciation and Amortization | 747.00M | 734.00M | 791.00M | 836.00M | 839.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 119.00M | -228.00M | -162.00M | -126.00M | -469.00M |
| Change in Net Operating Assets | 594.00M | 30.00M | -216.00M | -787.00M | 1.72B |
| Cash from Operations | 3.29B | 2.17B | 1.96B | 1.25B | 3.72B |
| Capital Expenditure | -480.00M | -272.00M | -301.00M | -347.00M | -405.00M |
| Sale of Property, Plant, and Equipment | 17.00M | 20.00M | 16.00M | 4.00M | 11.00M |
| Cash Acquisitions | 0.00 | -3.13B | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 483.00M | -194.00M | 32.00M | -1.69B | 18.00M |
| Cash from Investing | 20.00M | -3.58B | -253.00M | -2.03B | -376.00M |
| Total Debt Issued | 0.00 | 0.00 | -1.00M | 1.21B | 2.48B |
| Total Debt Repaid | -2.50B | -1.11B | -- | -- | -3.78B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.00B | 0.00 | 0.00 | -3.00B | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -149.00M | -150.00M | -149.00M | -135.00M | -136.00M |
| Other Financing Activities | -17.00M | 67.00M | 35.00M | 109.00M | 14.00M |
| Cash from Financing | -3.67B | -1.19B | -115.00M | -1.82B | -1.43B |
| Foreign Exchange rate Adjustments | -273.00M | 175.00M | -15.00M | 22.00M | 10.00M |
| Miscellaneous Cash Flow Adjustments | -1.00M | 0.00 | 1.00M | -- | -- |
| Net Change in Cash | -630.00M | -2.43B | 1.58B | -2.58B | 1.93B |
